Andrea_George

Andrea George

Andi George is a senior reviewer for the Office of Biotechnology Products (OBP) in the Center for Drug Evaluation and Research (CDER) at FDA. She serves as a member of the ICH Q12 working group in OBP and participated in the Established Conditions Pilot Program in 2019. Before joining FDA, Dr. George studied mammary stem cell biology as a post-doctoral fellow at the National Institutes of Health (NIH). Dr. George received her Ph.D. in Microbiology and Immunology from New York Medical College in Valhalla, NY.

Appearances

This speaker has made no appearances.